Australia: Health Alert (Australia) - 28 January 2014



23 January 2014 - AstraZeneca AB v Alphapharm Pty Ltd [2014] FCA 9

AstraZeneca AB and AstraZeneca Pty Ltd, as prospective applicants, issued an originating application against Alphapharm, as prospective respondent, requesting pre-action discovery and inspection of documents, plus delivery of samples, relating to Alphapharm products.

AstraZeneca distributes a successful proton pump inhibitor that reduces production of stomach acid. It considered Alphapharm's products could infringe one or more patents it holds for that product.

AstraZeneca's application was allowed in part. Alphapharm complied with the orders but the documents provided did not satisfy AstraZeneca. AstraZeneca filed and served an Amended Originating Application, seeking further orders for discovery and inspection of specific documents and delivery of samples, pursuant to Rule 7.23 of the Federal Court Rules 2011 (Cth).

AstraZeneca relied specifically on Rule 7.23(1)(b), arguing it had insufficient information to decide whether to initiate proceedings to obtain relief for the threatened infringement of a particular patent, as its expert could not form a firm opinion regarding similarities between the products. Alphapharm maintained that this reference to "firm opinion" meant AstraZeneca was requesting more than just the "sufficient information" required for the purposes of the Rule.

Besanko J disagreed, concluding that the issue of what is "sufficient information" is very fact specific. He cited a Full Court decision explaining "that even where there is a reasonable cause to believe a person may have a right to relief ... that person may need information to know whether the cost and risk of litigation is worthwhile." He allowed the further discovery and inspection, but not delivery of samples.

16 January 2014 - Davie and Comcare, Re [2014] AATA 1

Compensation – Commonwealth employee – whether medications prescribed for compensable back injury caused sensorineural hearing loss and tinnitus – relevance of Statement of Principles in claims under Safety Rehabilitation and Compensation Act 1988 – comparative evidentiary value of various research studies and reports of general application and specifically focused expert medical evidence – burden and standard of proof – decision affirmed.


2 August 2013 - Psychology Board of Australia v Freeman [2013] QCAT 701

These proceedings stemmed from a complaint made that Dr Freeman's behaviour constituted unsatisfactory professional conduct. The complaint was made by a prisoner for whom Dr Freeman prepared a report concerning the complainant's application for parole. Dr Freeman diagnosed the complainant with borderline personality disorder, which was alleged to be an inappropriate diagnosis. It was also alleged that Dr Freeman reported on the complainant's psychopharmacological regime "inappropriately and beyond his qualifications." This decision concerned Dr Freeman's application to have Professor Smallbone's expert evidence excluded on the basis that he was "not an entirely independent witness, free from any actual or perceived bias or conflict of interest."

Professor Smallbone had previously provided reports to the Board in disciplinary proceedings against Dr Freeman following complaints made by two other prisoners. Dr Freeman questioned the appropriateness of calling a member of the profession who had previously formed an adverse view of his professional standards to express an opinion on those standards in another matter. He submitted that an objective onlooker would conclude Professor Smallbone was biased, and his evidence should therefore not be admitted.

It was agreed that expert evidence is admissible where the expert is qualified by training or experience to give expert evidence, and where there is no other rule disqualifying the evidence. As Dr Freeman did not challenge the relevance of Professor Smallbone's opinions or his expertise, the judge held the evidence admissible and dismissed the application.

United Kingdom

23 January 2014 - Jones v Portsmouth Hospitals NHS (National Health Service) Trust [2014] EWHC 42 (QB). Necrotising myositis is a rare condition with a high mortality rate which in July 2008 infected the upper right thigh of Mrs Karen Jones, the Claimant. It led to the progressive removal of all the muscles in her upper right thigh and the recommendation to amputate her right leg through the knee. The necrotising myositis was caused by Group A streptococcal bacteria, which probably started with a sore throat that the Claimant had had during the week leading up to her admission to Queen Alexandra Hospital in Portsmouth.

23 January 2014 - C v North Cumbria University Hospitals NHS Trust [2014] EWHC 61 (QB). This case concerns a narrow question: Was it negligent for a midwife to administer a second dose of a drug that induces labour?


Amendment statement of principles concerning posttraumatic stress disorder No. 19 of 2014.

National health (efficient funding of chemotherapy) special arrangement amendment instrument 2014 (No. 1) (No. PB 5 of 2014).

Aged Care Act 1997 - Determination under paragraph 44-19(1)(b) (ACA Ch. 3 No. 5/2007) Revocation Determination 2013.


Australia. Department of Health & Ageing

Private Health insurance (PHI) Circulars

8 January 2014 - PHI 01/14. Release of final data specifications for the hospital casemix protocol (HCP), private hospital data bureau (PHDB) and GT Dental 2013-14 data collections.

8 January 2014 - Private health insurance (data provision) rules 2013 & private health insurance (health insurance business) rules 2013.

9 January 2014 - New version (version of check-it 2 released.

17 January 2014 - Private hospital information.

20 January 2014 - Private health insurance (incentives) amendment rules 2013 (No. 1) and private health insurance (complying product) amendment rules 2013 (No. 5).

23 January 2014 - Hospital information - name change.

Australia. Health Practitioner Regulation Agency (AHPRA) and the boards

24 January 2014 - All AHPRA offices will be closed on Monday 27 January 2014 due to the Australia Day national public holiday.

22 January 2014 - The national psychology board has released January 2014 figures on area of practice endorsements. Read More.

Australia. National Health & Medical Research Council (NHMRC)

17 January 2014 - Minor amendments to the Australian immunisation handbook 10th edition. The NHMRC Chief Executive Officer has approved minor amendments to the Australian immunisation handbook 10th edition under section 14A of the National Health and Medical Research Council Act 1992. The Australian immunisation handbook provides clinical information for Australian immunisation providers on the safest and most effective use of vaccines, new vaccines and vaccine-preventable diseases in Australia. The minor amendments include text clarifications, updates, corrections and typographical errors.

Australia. Therapeutic Goods Administration

21 January 2014 - Liko overhead lifts ceiling-mounted rail systems. Consumers and health professionals are advised that Hill-Rom is undertaking a recall for product correction regarding ceiling-mounted rail systems.

20 January 2014 - Generic prescription medicines: Fact sheet on generic medicines for consumers.

17 January 2014 - Joint reclassification advice: summary technical reports as interim conformity assessment evidence for partial joint components. This information is intended for sponsors seeking to reclassify partial hip, knee and shoulder implants.

17 January 2014 - Reclassification of partial hip, knee and shoulder implants. Summary technical reports will be accepted as interim evidence to support applications for partial joint components.

17 January 2014 - Australian Public Assessment Reports for prescription medicines (AusPARs). Added Alogliptin as benzoate (Vipidia/Nesina).

Australian Institute of Health & Welfare

24 January 2014 - Medical workforce 2012 media release.

Australian Commission on Safety and Quality in Health Care

20 January 2014 - On the Radar – Issue 158 (103KB).

New South Wales (NSW). Ministry of Health

Media Releases

20 January 2014 - Record number of intern doctors in 2014.

21 January 2014 - Scholarships open for diploma of enrolled nursing.

22 January 2014 - NSW medical devices fund stage two preliminary applications open.

23 January 2014 - Project team appointed to plan next stage of St George hospital redevelopment.

Information Bulletins

17 January 2014 - Medical speciality coding in StaffLink.

Queensland. Department of Health

21 January 2014 - Queensland health repayments hit $3.5 million. In the past fortnight, another 1,000 Queensland health staff have committed to repaying an additional $1 million in overpayments caused by the former Labor Government's health payroll system failure.

21 January 2014 - More telehealth services for the south west. Queenslanders in the south west can look forward to more telehealth services.

Victoria. Department of Health

19 January 2014 - Victorians warned against deadly impact of tanning. A campaign urging Victorians to guard against the dangerous effects of excessive sun exposure will hit television screens again this summer.

Western Australia (WA). Department of Health

Operational Directives (OD)

23 January 2014 - OD 0486/14 WA health patient identification policy 2014 describes the content, colour and use of patient identification bands for all inpatients, emergency department and day procedure patients in WA hospitals.

New Zealand (NZ). Ministry of Health

17 January 2014 - Psychoactive substances manufacturing code now in force. Psychoactive substance manufacturers are now subject to the requirements of the new Code of Manufacturing Practice. Read more.

16 January 2014 - Gestational Trophoblastic Disease: New Zealand Gynaecologic Cancer Group guidelines. This guideline outlines the management of women after the diagnosis of molar pregnancy in NZ as agreed to by the NZ Gynaecological Cancer Group. Read more.

United Kingdom. Department of Health

23 January 2014 - Making mental health as important as physical health.

23 January 2014 - Treating patients as people.

23 January 2014 - NHS availability of erectile dysfunction drugs: proposed changes.

23 January 2014 - Consultation to improve regulation of health and social care providers.

21 January 2014 - Care needs: financial services industry to develop products to help people plan.

20 January 2014 - Making mental health matter more.

17 January 2014 - Progress on suicide prevention.

United States of America (US). Department of Health & Human Services (HHS)

23 January 2014 - US and UK working to strengthen use of health information technology for better patient care.

22 January 2014 - New committee to advise HHS on needs of children in disasters.

17 January 2014 - Surgeon General report says 5.6 million US children will die prematurely unless current smoking rates drop.

Australian Medical Association (AuMA)

22 January 2014 - AuMA to call for national action on alcohol – media conference in Sydney. Read more.

23 January 2014 - Time for a National Summit on alcohol misuse and harms - AuMA. The AuMA is today calling on the Federal Government to convene a National Summit to discuss and assess the evidence and develop effective national solutions to the epidemic of alcohol misuse and harms afflicting local communities right across the nation. Read more

British Medical Association (BMA)

20 January 2014 - BMA backs "self-care" campaign. A national "self-care" campaign, aimed at diverting pressures away from primary and secondary care, has been backed by the BMA.

20 January 2014 - Royal colleges urged to act on exam diversity findings. All medical royal colleges should monitor and evaluate the diversity of candidates taking their exams, a BMA review has urged.

17 January 2014 - Restraint of immigrant detainees alarms BMA. The BMA has expressed concern over the way frail and seriously ill immigrants at a UK detention centre were restrained during medical treatment.

17 January 2014 - Can a cash reward encourage breastfeeding? The overall health of society is determined by individual choice. Every day people choose to breastfeed, lose weight and give up smoking - but would more do so for a cash reward?

17 January 2014 - BMA secures "acting-up" allowance for SAS doctors. Specialty doctors will be recognised for acting up in the role of consultants, following successful BMA negotiations.

Canadian Medical Association (CMA)

23 January 2014 - New e-newsletter to feature customized content, far larger readership. Thanks to a relaunch of the CMA's e-newsletter, circulation is going to triple to 60,000 members in January, and for the first time the content they receive will be customized according to their membership in the student, resident or practising/retired member category.

20 January 2014 - Medical Doctors (MD) avoiding social media in droves: poll.

17 January 2014 - CMA acts on physician employment worries.

American Medical Association (AMA)

23 January 2014 - "A lot less of House, MD, and more of Car Talk:" A peek at medicine's future. As the nation considers ways to lower unsustainable health care costs and enhance the quality of patient care, renowned diagnostician Gurpreet Dhaliwal, MD, says physicians can learn valuable lessons from Click and Clack, longtime hosts of the popular Car Talk radio program.

23 January 2014 - Quality of clinical trial evidence varies greatly in Food and Drug Administration's (FDA)'s drug approval process. A new study in the Journal of the American Medical Association examined the US Food and Drug Administration's approval process for about two hundred new drugs over the past several years. The study found the quality of clinical trial evidence used by the FDA as the basis for recent approvals of novel therapeutic agents varied widely.

22 January 2014 - New faculty training program aims to transform medical education. A select group of faculty members of the Brody School of Medicine at East Carolina University are embarking on a year-long professional development program designed to develop skills for implementing new practice design and new curricula for today's environment of team based care.

21 January 2014 - How the AMA is easing physicians' regulatory loads. An AMA viewpoints post by AMA President Ardis Dee Hoven, MD. We physicians are part of so many powerful stories: Stories of injuries healed, cancers overcome and chronic conditions brought under control. But there's another story happening behind the scenes of clinical care that others need to hear.

© DLA Piper

This publication is intended as a general overview and discussion of the subjects dealt with. It is not intended to be, and should not used as, a substitute for taking legal advice in any specific situation. DLA Piper Australia will accept no responsibility for any actions taken or not taken on the basis of this publication.

DLA Piper Australia is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. For further information, please refer to

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
DLA Piper Australia
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Similar Articles
Relevancy Powered by MondaqAI
DLA Piper Australia
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions